Michael Barbella, Managing Editor04.16.24
Verasonics Inc. has appointed Christian Coviello, Ph.D., as director of Ultrasound Science and Andrew Lundberg as director of Hardware Engineering and Operations.
“Verasonics is focused on enabling researchers and developers to break barriers in ultrasonic science via novel capabilities with the Vantage NXT Research Ultrasound platform,” Verasonics President/CEO Jon K. Daigle said. “With the evolution of our Ultrasound Science Team, which is now 10 expert scientists strong, and the expanded focus on engineering and operations, we continue on our mission to enable our customers and to advance ultrasound research and development. The additions of Christian and Andrew to our team enhance the deep expertise resident in our research and development teams. Christian is leading our ultrasound innovation activities and growing relationships with our Scientific Advisory Board members, as well as industry leaders. Andrew’s extensive skill set allows the organization to expand hardware engineering and operational efficiencies through stronger processes and procedures. Together, they are focused on advancing Vantage research platform capabilities.”
Dr. Coviello earned a doctorate in philosophy from Pennsylvania State University and a bachelor of science degree from Bucknell University, both in electrical engineering. Most recently, Dr. Coviello served as chief technology officer at OxSonics Therapeutics, a spin-out company he co-founded focused on ultrasound-enhanced drug delivery. Prior to OxSonics, he was a post-doctoral research fellow at the University of Oxford and a senior scientist with SAIC (Leidos) in the Advanced Systems and Technology Division working on image and signal processing algorithm development. He currently serves on the board of the International Society for Therapeutic Ultrasound and is a member of the International Electrotechnical Commission Cavitation Standard Project Team.
Lundberg earned a masters degree in medical engineering and a bachelor of science degree in electrical engineering from the University of Washington. He is an engineering leader with more than 26 years of experience in the design of medical ultrasound systems. Before Verasonics, Lundberg was director of Hardware Engineering at FUJIFILM SonoSite. He held several other engineering roles during his company tenure.
Verasonics is a privately held company founded in 2001, with headquarters in Kirkland, Wash. Verasonics deems itself the leader in research ultrasound and provides advanced and flexible tools for developing new algorithms and products used in biomedical ultrasound, materials science, earth sciences, and the physics of acoustics and ultrasonics. Verasonics also licenses its technology to companies for use in their commercial products. Researchers in countries throughout North and South America, Europe, Asia and Oceania routinely use Verasonics product solutions to advance ultrasound through their own research efforts.
“Verasonics is focused on enabling researchers and developers to break barriers in ultrasonic science via novel capabilities with the Vantage NXT Research Ultrasound platform,” Verasonics President/CEO Jon K. Daigle said. “With the evolution of our Ultrasound Science Team, which is now 10 expert scientists strong, and the expanded focus on engineering and operations, we continue on our mission to enable our customers and to advance ultrasound research and development. The additions of Christian and Andrew to our team enhance the deep expertise resident in our research and development teams. Christian is leading our ultrasound innovation activities and growing relationships with our Scientific Advisory Board members, as well as industry leaders. Andrew’s extensive skill set allows the organization to expand hardware engineering and operational efficiencies through stronger processes and procedures. Together, they are focused on advancing Vantage research platform capabilities.”
Dr. Coviello earned a doctorate in philosophy from Pennsylvania State University and a bachelor of science degree from Bucknell University, both in electrical engineering. Most recently, Dr. Coviello served as chief technology officer at OxSonics Therapeutics, a spin-out company he co-founded focused on ultrasound-enhanced drug delivery. Prior to OxSonics, he was a post-doctoral research fellow at the University of Oxford and a senior scientist with SAIC (Leidos) in the Advanced Systems and Technology Division working on image and signal processing algorithm development. He currently serves on the board of the International Society for Therapeutic Ultrasound and is a member of the International Electrotechnical Commission Cavitation Standard Project Team.
Lundberg earned a masters degree in medical engineering and a bachelor of science degree in electrical engineering from the University of Washington. He is an engineering leader with more than 26 years of experience in the design of medical ultrasound systems. Before Verasonics, Lundberg was director of Hardware Engineering at FUJIFILM SonoSite. He held several other engineering roles during his company tenure.
Verasonics is a privately held company founded in 2001, with headquarters in Kirkland, Wash. Verasonics deems itself the leader in research ultrasound and provides advanced and flexible tools for developing new algorithms and products used in biomedical ultrasound, materials science, earth sciences, and the physics of acoustics and ultrasonics. Verasonics also licenses its technology to companies for use in their commercial products. Researchers in countries throughout North and South America, Europe, Asia and Oceania routinely use Verasonics product solutions to advance ultrasound through their own research efforts.